Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The last obesity drugmaker to go public, Metsera, raised $275 million in its January 2025 IPO and was subsequently acquired by Pfizer for $65.60 per share in cash at closing, in a deal that attracted a competing $10 billion bid from Novo Nordisk before Pfizer ultimately prevailed
What to Expect After Treatment
Medical weight loss with GLP-1 medications requires regular monitoring and support
It acknowledges that the fatigue experienced in Long COVID and ME/CFS is not monolithic
Ptosis and piloerection were monitored as signs of successful sympathectomy
This is also a good time for your first body composition assessment (DEXA scan or equivalent)
US$ 25.75
US$ 29.19
US$ 29.52
US$ 25.38
US$ 27.66
US$ 25.32
US$ 29.43
US$ 24.40
US$ 23.58
